Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The group's high margin levels account for strong profits.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 88.71 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 114.42.
  • The group usually releases earnings worse than estimated.
  • With an enterprise value anticipated at 5.98 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company benefits from high valuations in earnings multiples.
Ratings chart
Sector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalisation (M$)Investor Rating
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPA..4.60%76 127
HOYA CORPORATION-2.28%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726
BAXTER INTERNATIONAL INC.-0.25%40 886
SARTORIUS STEDIM BIOTECH6.46%34 549
DEXCOM, INC.-4.20%34 013
ZIMMER BIOMET HOLDINGS3.91%33 189
TERUMO CORPORATION-4.04%30 113
SYSMEX CORPORATION4.52%25 867
WEST PHARMACEUTICAL SERVICE..5.68%22 135
AMERISOURCEBERGEN CORPORATI..9.25%21 861
BIO-RAD LABORATORIES, INC.3.12%17 956
AVANTOR, INC.2.84%16 743
STERIS PLC-2.72%15 732
More Results
Financials (USD)
Sales 2020 33 853 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 45,4x
Yield 2020 1,29%
Capitalization 191 B 191 B -
EV / Sales 2020 5,98x
EV / Sales 2021 5,21x
Nbr of Employees 107 000
Free-Float 88,9%
Upcoming event on ABBOTT LABORATORIES
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes